7Q19
Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3)
This is a non-PDB format compatible entry.
Summary for 7Q19
Entry DOI | 10.2210/pdb7q19/pdb |
Descriptor | Beta-lactoglobulin, 3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE, 1,2-ETHANEDIOL, ... (6 entities in total) |
Functional Keywords | lactoglobulin, mutation, desipramine, transport protein |
Biological source | Bos taurus (Bovine) |
Total number of polymer chains | 1 |
Total formula weight | 18906.90 |
Authors | Loch, J.I.,Barciszewski, J.,Pokrywka, K.,Lewinski, K. (deposition date: 2021-10-18, release date: 2022-05-11, Last modification date: 2024-01-31) |
Primary citation | Loch, J.I.,Barciszewski, J.,Sliwiak, J.,Bonarek, P.,Wrobel, P.,Pokrywka, K.,Shabalin, I.G.,Minor, W.,Jaskolski, M.,Lewinski, K. New ligand-binding sites identified in the crystal structures of [beta]-lactoglobulin complexes with desipramine Iucrj, 9:386-398, 2022 Cited by DOI: 10.1107/S2052252522004183PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.55 Å) |
Structure validation
Download full validation report